ConMed acquires MedShape’s ExoShape ACL portfolio

MedShape deals ExoShape ACL portfolio to ConMed (MassDevice) MedShape said today it inked a deal to divest its ExoShape ACL fixation system properties to ConMed (NSDQ:CNMD) for an undisclosed amount. The deal, which closed on Monday, includes Atlanta-based MedShape’s ExoShape femoral and tibial soft tissue fasteners designed to fixate soft tissue grafts in anterior cruciate ligament reconstructive surgery. “The ExoShape system has represented a valuable portion of MedShape’s business since 2011, and this acquisition further demonstrates the success of the development and commercialization effo...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top